Mentice AB Announces the Appointment of Lars Lonn as Clinical Director for Mentice

Saturday, March 29, 2008 General News J E 4
GOTHENBURG, Sweden, March 28 Mentice AB, a leadingsupplier of virtual reality based training applications within the field ofmedicine has recently appointed Lars Lonn as Clinical Director for Mentice.

Professor Lonn, an Interventional Radiologist, is also a leading Europeanprofessor within the field of Endovascular Surgery and a faculty member ofRigshospital Health Sciences in Copenhagen, Denmark.

Professor Lonn recently completed a study with Max Berry, MD, MikaelHellstrom, MD, Jan Gothlin, MD, and Richard Reznick, MD, MEd, FRCSC, which wasfeatured in the Journal of Vascular Interventional Radiology entitled,"Endovascular Training with Animals versus Virtual Reality Systems: AnEconomic Analysis."

Goran Malmberg, CEO and President of Mentice said, "This is a monumentalstep forward for us. Professor Lonn will have a vital role with Menticeverifying the direction of our product development, while increasing theawareness and need for training solutions in healthcare. In the long run, wefeel that Clinical Directors will play a vital role in driving medicaltraining through the use of medical simulation."

About Mentice:

Mentice is a leader in medical simulation with approximately 600installations worldwide, 100 validation studies and more than 30 issued andpending patents. Mentice's Family of Procedicus (TM) simulators focus on thearea of minimally invasive surgery within the fields of endovascularintervention, core skills training, laparoscopy and arthroscopy training.

Website info:

For more information contact: Goran Malmberg at +46 31 33 99 401(Gothenburg office) or email,

Release #32808

SOURCE Mentice Inc.


You May Also Like

View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
Tiens Biotech Group (USA) Reports Fourth Quarter a...
Actor Greg Grunberg Meets With the Epilepsy Advoca...